Global Demand for Standardized Green Tea Extract Surges Following JAMA Oncology Publication

Title: Global Demand for Standardized Green Tea Extract Surges Following JAMA Oncology Publication

Meta Description: Global demand for standardized Green Tea Extract surges after JAMA Oncology publication. Blue Eyes Biotech ensures a reliable, high-quality supply for the nutraceutical industry.

Article:

The global nutraceutical market is experiencing a significant surge in demand for standardized Green Tea Extract, a trend directly catalyzed

by a major publication in JAMA Oncology in late 2023. The large-scale, prospective cohort study demonstrated a clear inverse association

between regular consumption of high-EGCG green tea extracts and the incidence of several cancer types, particularly those of the breast,

prostate, and colorectal regions. This high-impact, authoritative publication has reverberated through the industry, alerting both consumers

and manufacturers to the validated preventive potential of well-characterized Green Tea Extract. Consequently, brands worldwide are racing

to reformulate and launch products that feature a standardized, high-potency EGCG content, placing unprecedented pressure on the supply

chain for quality-assured raw material. Blue Eyes Biotech CO., Ltd. is strategically positioned to meet this escalating global demand with

a robust and scalable supply of premium, standardized Green Tea Extract. Our vertically integrated operations, from the sourcing of select

Camellia sinensis leaves to final extraction and purification, allow us to maintain strict control over quality and ensure a consistent, reliable

supply. We operate state-of-the-art facilities compliant with international cGMP standards, enabling us to produce our signature 95% EGCG

Green Tea Extract at a scale that meets the needs of the world's largest supplement brands without compromising on quality.

For companies seeking to capitalize on this market opportunity, the challenges extend beyond mere supply to issues of quality and

documentation. Blue Eyes Biotech provides comprehensive support, including detailed Certificates of Analysis, stability data, and full

traceability of our raw materials. This level of transparency is essential for brands that need to substantiate their label claims and build

consumer trust in an increasingly discerning market. By partnering with Blue Eyes Biotech, nutraceutical companies can secure their supply

of a critical, in-demand ingredient, ensuring they can confidently bring high-quality, evidence-based Green Tea Extract products to market

that align with the latest and most influential scientific research. For sourcing inquiries, please contact us at [email protected].